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Abstract: Mobilized colistin resistance (<jats:italic>mcr</jats:italic>) genes are plasmid-borne genes
that confer resistance to colistin, an antibiotic used to treat severe bacterial infections. To date, eight
known <jats:italic>mcr</jats:italic> homologues have been described (<jats:italic>mcr-1</jats:italic>
to <jats:italic>-8</jats:italic>). Here, we describe <jats:italic>mcr-9</jats:italic>, a novel <jats:italic>mcr</jats:italic>
homologue detected during routine <jats:italic>in silico</jats:italic> screening of sequenced <jats:italic>Salmonella</jats:italic>
genomes for antimicrobial resistance genes. The amino acid sequence of <jats:italic>mcr-9</jats:italic>,
detected in a multidrug-resistant (MDR) <jats:named-content content-type=”genus-species”>Salmonella
enterica</jats:named-content> serotype Typhimurium (<jats:italic>S</jats:italic>. Typhimurium) strain
isolated from a human patient in Washington State in 2010, most closely resembled <jats:italic>mcr-
3</jats:italic>, aligning with 64.5% amino acid identity and 99.5% coverage using Translated Nucleotide
BLAST (tblastn). The <jats:italic>S.</jats:italic> Typhimurium strain was tested for phenotypic re-
sistance to colistin and was found to be sensitive at the 2-mg/liter European Committee on Antimicro-
bial Susceptibility Testing breakpoint under the tested conditions. <jats:italic>mcr-9</jats:italic> was
cloned in colistin-susceptible <jats:named-content content-type=”genus-species”>Escherichia coli</jats:named-
content> NEB5￿ under an IPTG (isopropyl-￿-<jats:sc>d</jats:sc>-thiogalactopyranoside)-induced pro-
moter to determine whether it was capable of conferring resistance to colistin when expressed in a heterolo-
gous host. Expression of <jats:italic>mcr-9</jats:italic> conferred resistance to colistin in <jats:named-
content content-type=”genus-species”>E. coli</jats:named-content> NEB5￿ at 1, 2, and 2.5 mg/liter
colistin, albeit at a lower level than <jats:italic>mcr-3</jats:italic>. Pairwise comparisons of the pre-
dicted protein structures associated with all nine <jats:italic>mcr</jats:italic> homologues (Mcr-1 to -9)
revealed that Mcr-9, Mcr-3, Mcr-4, and Mcr-7 share a high degree of similarity at the structural level. Our
results indicate that <jats:italic>mcr-9</jats:italic> is capable of conferring phenotypic resistance to col-
istin in <jats:named-content content-type=”genus-species”>Enterobacteriaceae</jats:named-content>
and should be immediately considered when monitoring plasmid-mediated colistin resistance. <jats:bold>IMPORTANCE</jats:bold>
Colistin is a last-resort antibiotic that is used to treat severe infections caused by MDR and extensively
drug-resistant (XDR) bacteria. TheWorld Health Organization (WHO) has designated colistin as a “high-
est priority critically important antimicrobial for human medicine” (WHO, <jats:italic>Critically Im-
portant Antimicrobials for Human Medicine</jats:italic>, <jats:italic>5th revision</jats:italic>, 2017,
<jats:ext-link xmlns:xlink=”http://www.w3.org/1999/xlink” ext-link-type=”uri” xlink:href=”https://www.who.int/foodsafety/publications/antimicrobials-
fifth/en/”>https://www.who.int/foodsafety/publications/antimicrobials-fifth/en/</jats:ext-link>), as it
is often one of the only therapies available for treating serious bacterial infections in critically ill pa-
tients. Plasmid-borne <jats:italic>mcr</jats:italic> genes that confer resistance to colistin pose a
threat to public health at an international scale, as they can be transmitted via horizontal gene trans-
fer and have the potential to spread globally. Therefore, the establishment of a complete reference of
<jats:italic>mcr</jats:italic> genes that can be used to screen for plasmid-mediated colistin resistance
is essential for developing effective control strategies.
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ABSTRACT Mobilized colistin resistance (mcr) genes are plasmid-borne genes that
confer resistance to colistin, an antibiotic used to treat severe bacterial infections. To
date, eight known mcr homologues have been described (mcr-1 to -8). Here, we de-
scribe mcr-9, a novel mcr homologue detected during routine in silico screening of
sequenced Salmonella genomes for antimicrobial resistance genes. The amino acid
sequence of mcr-9, detected in a multidrug-resistant (MDR) Salmonella enterica sero-
type Typhimurium (S. Typhimurium) strain isolated from a human patient in Wash-
ington State in 2010, most closely resembled mcr-3, aligning with 64.5% amino acid
identity and 99.5% coverage using Translated Nucleotide BLAST (tblastn). The S. Typhi-
murium strain was tested for phenotypic resistance to colistin and was found to be sen-
sitive at the 2-mg/liter European Committee on Antimicrobial Susceptibility Testing
breakpoint under the tested conditions. mcr-9 was cloned in colistin-susceptible Esche-
richia coli NEB5 under an IPTG (isopropyl--D-thiogalactopyranoside)-induced promoter
to determine whether it was capable of conferring resistance to colistin when
expressed in a heterologous host. Expression of mcr-9 conferred resistance to
colistin in E. coli NEB5 at 1, 2, and 2.5 mg/liter colistin, albeit at a lower level than
mcr-3. Pairwise comparisons of the predicted protein structures associated with all
nine mcr homologues (Mcr-1 to -9) revealed that Mcr-9, Mcr-3, Mcr-4, and Mcr-7
share a high degree of similarity at the structural level. Our results indicate that
mcr-9 is capable of conferring phenotypic resistance to colistin in Enterobacteriaceae
and should be immediately considered when monitoring plasmid-mediated colistin
resistance.
IMPORTANCE Colistin is a last-resort antibiotic that is used to treat severe infections
caused by MDR and extensively drug-resistant (XDR) bacteria. The World Health Organi-
zation (WHO) has designated colistin as a “highest priority critically important antimicro-
bial for human medicine” (WHO, Critically Important Antimicrobials for Human Medicine,
5th revision, 2017, https://www.who.int/foodsafety/publications/antimicrobials-ﬁfth/en/), as
it is often one of the only therapies available for treating serious bacterial infections
in critically ill patients. Plasmid-borne mcr genes that confer resistance to colistin
pose a threat to public health at an international scale, as they can be transmitted
via horizontal gene transfer and have the potential to spread globally. Therefore,
the establishment of a complete reference of mcr genes that can be used to screen
for plasmid-mediated colistin resistance is essential for developing effective control
strategies.
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Until recently, bacterial resistance to colistin, a last-resort antibiotic reserved fortreating severe infections, was thought to be acquired solely via chromosomal
point mutations (1). However, in 2015, plasmid-mediated colistin resistance gene mcr-1
was described in Escherichia coli (1). Mcr-1 is a phosphoethanolamine transferase that
modiﬁes cell membrane lipid A head groups with a phosphoethanolamine residue,
reducing afﬁnity to colistin (2). Since then, seven additional mcr homologues (mcr-2 to
-8) have been identiﬁed in Enterobacteriaceae (3–9). Here, we report novel mcr homo-
logue mcr-9, which was identiﬁed in a Salmonella enterica serotype Typhimurium (S.
Typhimurium) genome.
In silico identiﬁcation of mcr-9 in an MDR S. Typhimurium genome. MDR
S. Typhimurium strain HUM_TYPH_WA_10_R9_3274 (NCBI RefSeq accession no.
GCF_002091095.1) was isolated from a patient in Washington State in 2010 (10). It had
previously been tested for resistance to a panel of 12 antimicrobials that did not include
colistin (10). ABRicate version 0.8 (https://github.com/tseemann/abricate) identiﬁed 20
antimicrobial resistance (AMR) genes in the HUM_TYPH_WA_10_R9_3274 assembly
using the ResFinder database (accessed 11 June 2018) (11) and minimum identity and
coverage thresholds of 75 and 50% (10), respectively, none of which had been
previously described to confer colistin resistance (see Table S1 in the supplemental
material). Four plasmid replicons, including IncHI2 and IncHI2A, were detected with at
least 80% identity and 60% coverage using ABRicate and PlasmidFinder (accessed 11
June 2018 [Table S1]) (12).
To detectmcr-9 in the HUM_TYPH_WA_10_R9_3274 assembly, all colistin resistance-
conferring nucleotide sequences available in ResFinder (52 sequences, accessed 22
January 2019 [see Table S2 in the supplemental material]) were translated into amino
acid sequences using EMBOSS Transeq (reading frame 1 [https://www.ebi.ac.uk/Tools/
st/emboss_transeq/]). The implementation of Translated Nucleotide BLAST (tblastn)
(13) in BTyper version 2.3.2 (14) selected mcr-3.17 as the highest-scoring mcr allele,
which aligned to mcr-9 with 64.5% amino acid identity and 99.5% coverage (Table S1).
MUSCLE version 3.8.31 (15) was used to construct alignments of the amino acid
sequence of mcr-9 (NCBI protein accession no. WP_001572373.1) and the following: (i)
the 52 mcr amino acid sequences from ResFinder (53 sequences [Table S2]), (ii) the top
100 hits produced when mcr-9 was queried against NCBI’s non-redundant protein (nr)
database using the Protein BLAST (blastp) web server (https://blast.ncbi.nlm.nih.gov/
Blast.cgi?PAGEProteins [accessed 22 January 2019]; 152 sequences excluding mcr-9’s
self-match [see Table S3 in the supplemental material]), and (iii) amino acid sequences
of 61 putative phosphoethanolamine transferases used in other papers describing
novelmcr genes (4, 5, 8, 9) (213 sequences [see Table S4 in the supplemental material]).
For each alignment, RAxML version 8.2.12 (16) was used to construct a phylogeny using
the PROTGAMMAAUTO method and 1,000 bootstrap replicates.
The amino acid sequence of mcr-9 most closely resembled those of mcr-3 and mcr-7
(Fig. 1A; see Fig. S1 in the supplemental material). However, the S. Typhimurium isolate
in which mcr-9 was detected was not resistant to colistin at the 2-mg/liter European
Committee on Antimicrobial Susceptibility Testing (EUCAST [http://www.eucast.org])
breakpoint when a broth microdilution method was used to determine the colistin MIC
(see Table S5 in the supplemental material).
mcr-9 confers resistance to colistin when cloned into colistin-susceptible E. coli
NEB5. Coding regions of mcr-9 and mcr-3 were cloned under the control of an IPTG
(isopropyl--D-thiogalactopyranoside)-induced SPAC/lacOid promoter and expressed in
E. coli NEB5 (see Text S1 in the supplemental material). Colistin killing assays (Fig. 1B;
see Fig. S2 in the supplemental material) were performed by incubating E. coli harbor-
ing the empty pLIV2 vector (negative control), pLIV2 with mcr-3 (positive control), or
pLIV2 with mcr-9 with different concentrations of colistin (0, 1, 2, 2.5, and 5 mg/liter). E.
coli cells harboring the empty vector failed to survive at all tested colistin concentra-
tions 0 mg/liter. While mcr-3 expression conferred clinical levels of colistin resistance
(i.e., beyond the 2-mg/liter EUCAST breakpoint) in E. coli at all tested concentrations,
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mcr-9 expression conferred clinical resistance at 1, 2, and 2.5 mg/liter, but not 5 mg/liter
of colistin (Fig. 1B; Fig. S2).
Mcr-3, Mcr-4, Mcr-7, and Mcr-9 are highly similar at the structural level.
Three-dimensional (3D) structural models of all nine Mcr homologues (Fig. 2A) based on
EptA (2) were constructed using the Phyre2 server (17) and visualized using UCSF
Chimera (18). Congruent with the phylogeny based on their amino acid sequences
(Fig. 1A), comparisons of different Mcr protein models using Dali (19) revealed that
Mcr-3, Mcr-4, Mcr-7, and Mcr-9 were closely related at the structural level (Fig. 1C).
Proteins encoded by mcr-1 to -9 revealed high levels of conservation for both the
membrane-anchored domain and the soluble catalytic domain (Fig. 2A). Interestingly,
analyses of structural models of the nine Mcr homologues using the ESPript 3 server
(20) showed that both amino acids and structural elements were conserved on the
C-terminal catalytic domain, while only structural elements were conserved on the
membrane-anchored N-terminal domain (Fig. 2B).
FIG 1 (A) Comparison of mcr-9 to all previously described mcr homologues, based on amino acid sequence. The maximum likelihood phylogeny was
constructed using RAxML version 8.2.12 with the amino acid sequences of novel mobilized colistin resistance gene mcr-9 (in blue) and all previously described
mcr genes (mcr-1 to -8 [in black]). The phylogeny is rooted at the midpoint, with branch lengths reported in substitutions per site. Branch labels correspond
to bootstrap support percentages out of 1,000 replicates. (B) Colistin killing assay of E. coli NEB5 harboring a pLIV2 empty vector (negative control), mcr-3
(positive control), or mcr-9, expressed under the control of the IPTG-controlled SPAC/lacOid promoter. Cells were grown in MH-II (Mueller-Hinton II) medium
with IPTG to the mid-exponential phase. Colistin was added at concentrations of 0, 1, 2, 2.5, or 5 mg/liter, and the bacteria were incubated at 37°C for 1 h. The
samples were diluted in phosphate-buffered saline (PBS) and plated on LB agar plates for the determination of CFU. Log CFU reduction was calculated by
comparing CFU after each treatment to CFU levels obtained at 0 mg/liter colistin, using three independent biological replicates. Asterisks denote signiﬁcant
differences compared to empty vector treatment (P  0.05 by Student’s t test relative to the concentration’s respective negative control after a Bonferroni
correction). (C) Similarity matrix (composed of Dali Z-scores) of all previously described Mcr groups (Mcr-1 to -8) and Mcr-9, based on protein structure. The Dali
server was used to perform all-against-all comparisons of 3D structural models based on all mcr homologues (Fig. 2A); for this analysis, amino acid sequences
ofmcr-5.3 andmcr-8.2, which were not available in ResFinder, were additionally included from the National Database of Antibiotic Resistant Organisms (NDARO).
Novel Mobilized Colistin Resistance Gene mcr-9 ®
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Numerous genera of Enterobacteriaceae harbor mcr-9 on IncHI2 plasmids.
blastp searches of mcr-9 against NCBI’s nr database revealed that mcr-9 was present in
multiple genera of Enterobacteriaceae (Table S3). The 10 highest-scoring hits in the nr
database matched mcr-9 with at least 99% amino acid identity (including mcr-9
characterized here [Table S3 and Fig. S1A]); the amino acid identities of the remaining
hits with high query coverage ( 90%) dropped below 88% identity (Table S3 and
Fig. S1A). mcr-9 was detected in 335 genomes linked to NCBI identical protein groups
(IPGs) associated with the 10 highest-scoring protein accession numbers (accessed 23
January 2019 [see Tables S3 and S6 in the supplemental material]). Analysis of themcr-9
promoter region in 321 of these genomes (Text S1) showed conserved putative 70
family-dependent 35 and 10 regions and an inverted repeat (Fig. 2C). The con-
FIG 2 (A) Structural models of all published Mcr proteins (Mcr-1 to -8) and Mcr-9, based on lipooligosaccharide phosphoethanolamine transferase EptA. Models
were constructed using the Phyre2 server, and structures were viewed and edited using UCSF Chimera. Structural models show conservation of two EptA
domains: transmembrane-anchored and soluble periplasmic domains. (B) Location of Mcr-9 secondary structure elements within the alignment of Mcr amino
acid sequences, constructed using the ESPript 3 server. The top track denotes Mcr-9 secondary structure elements (alpha helixes and beta sheets). Green digits
below the alignment denote cysteine residues forming a disulﬁde bridge (e.g., 1 forms a bridge with 1, 2 with 2, etc.). Within the amino acid sequence alignment
itself, a strict identity (i.e., identical amino acid residue at a site) is denoted by a red box and a white character. A yellow box around an amino acid residue
denotes similarity across groups, where groups were deﬁned using the default “all” speciﬁcation in ESPript 3 (ESPript 3 total score [TSc]  in-group threshold
[ThIn]), while a residue in boldface denotes similarity within a group (ESPript 3 in-group score [ISc]  ThIn). (C) Organization of the mcr-9 locus in S.
Typhimurium. An unknown function cupin fold metalloprotein is encoded by the gene downstream of mcr-9 (unlabeled black arrow). The mcr-9 locus is ﬂanked
by two different terminal repeat sequences (IRR) from the IS5 (orange box) and IS6 (red box) families. The mcr-9 upstream region contains highly conserved
putative 35 and 10 70-dependent promoter elements (blue boxes and blue text). Moreover, the mcr-9 promoter region contains an inverted repeat motif
(green box, green text, and sequence logo) that is conserved in more than 95% of 321 mcr-9 genes, as shown by the sequence logo (constructed using
WebLogo) (24).
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served DNA motif in the mcr-9 promoter is likely a recognition sequence for a
transcription regulator, suggesting that additional factors or induction/derepression
conditions might be needed for full expression of wild-type mcr-9. Promoter variation
(21) and testing conditions (22, 23) have been shown to inﬂuence mcr expression and
the colistin MIC, which may explain why the S. Typhimurium strain queried here was
colistin susceptible under the tested conditions.
Of the 335 genomes in which mcr-9 was detected, 65 had at least one plasmid
replicon (detected using ABRicate and PlasmidFinder as described above) present on
the same contig as mcr-9; in 59 of these 65 genomes, IncHI2 and/or IncHI2A replicons
were detected on the same contig as mcr-9 (Table S6). In 32 of the 37 closed genomes
in which it was detected, mcr-9 was harbored on a plasmid (Table S6). These results
indicate that mcr-9 has the potential to reduce susceptibility to colistin, up to and
beyond the EUCAST breakpoint, and can be found extrachromosomally in multiple
species of Enterobacteriaceae, making it a relevant threat to public health. Future
studies querying the plasmids that harbor mcr-9 (e.g., transferability, stability, and copy
number variation) will offer further insight into the potential role thatmcr-9 plays in the
dissemination of colistin resistance worldwide.
Accession number(s). The nucleotide and amino acid sequences of mcr-9 are
available under NCBI reference sequence accession no. NZ_NAAN01000063.1 (NCBI
protein accession no. WP_001572373.1).
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